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Background: Obesity is associated with low-grade inflammation and impaired immune response. Caloric restriction
(CR) has been shown to inhibit inflammatory response and enhance cell-mediated immune function. Curcumin, the
bioactive phenolic component of turmeric spice, is proposed to have anti-obesity and anti-inflammation properties
while piperine, another bioactive phenolic compound present in pepper spice, can enhance the bioavailability and
efficacy of curcumin. This study sought to determine if curcumin could potentiate CR’s beneficial effect on immune
and inflammatory responses in obesity developed in mice by feeding high-fat diet (HFD).
Methods: Mice were fed a HFD for 22 wk and then randomized into 5 groups: one group remained on HFD ad
libitum and the remaining 4 groups were fed a 10% CR (reduced intake of HFD by 10% but maintaining the same
levels of micronutrients) in the presence or absence of curcumin and/or piperine for 5 wk, after which CR was
increased to 20% for an additional 33 wk. At the end of the study, mice were sacrificed, and spleen cells were
isolated. Cells were stimulated with T cell mitogens, anti-CD3/CD28 antibodies, or lipopolysaccharide to determine
T cell proliferation, cytokine production, and CD4+ T cell subpopulations.
Results: Compared to HFD control group, all CR mice, regardless of the presence of curcumin and/or piperine, had
lower body weight and fat mass, lower levels of blood glucose and insulin, and fewer total spleen cells but a
higher percentage of CD4+ T cells. Additionally, they demonstrated lower production of pro-inflammatory cytokines
IL-1β and TNF-α, a trend toward lower IL-6, and lower production of PGE2, a lipid molecule with pro-inflammatory
and T cell-suppressive properties. Mice with CR alone had higher splenocyte proliferation and IL-2 production, but
this effect of CR was diminished by spice supplementation. CR alone or in combination with spice supplementation
had no effect on production of cytokines IL-4, IL-10, IFN-γ, and IL-17, or the proportion of different CD4+ T cell
subsets.
Conclusion: CR on an HFD favorably impacts both metabolic and immune/inflammatory profiles; however, the
presence of curcumin and/or piperine does not amplify CR’s beneficial effects.
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Excessive energy intake results in weight gain leading to
obesity [1]. Obesity, which is increasing worldwide, is a
well-recognized risk factor for several chronic diseases
including diabetes, cardiovascular diseases, metabolic
syndrome, and several forms of cancer [2]. Obesity-
associated changes in number, distribution, and function
of immune cells are believed to be among the key contrib-
utors to the pathogenesis of these diseases. Furthermore,
obesity has been shown to be associated with an increased
susceptibility to infection [3,4]. Various strategies focused
on energy reduction or increasing energy expenditures
have been developed. However, there is clearly a lack of
effectiveness in most of these approaches as indicated by
the fact that the prevalence of obesity is escalating. Thus,
identifying food patterns or dietary components with
characteristics capable of accelerating weight loss in over-
weight individuals undergoing a weight reduction or
caloric restriction (CR) regimen would be of great value
and significance.
CR has been shown to modulate energy balance and
extend the survival and maximal lifespan in experimen-
tal animal models [5,6]. A limited number of studies
have demonstrated that CR favorably impacts immune
system functions including both innate and acquired
immunities [7-10]. Studies have also suggested that
certain dietary components, such as spices and their bio-
active components, may exert a beneficial effect on
obesity and related metabolic disorders. Among these
spices, curcumin, the major bioactive polyphenol present
in the spice turmeric, has been shown to possess antioxi-
dant, anticancer, anti-angiogenesis, anti-obesity and chemo-
therapeutic properties [11]. We and others have reported
that dietary curcumin supplementation reduces adiposity
and weight gain in a mouse model of high fat diet-induced
obesity [12,13]. Curcumin is also known to affect
several aspects of immune function including inhibition
of T cell proliferation, dendritic cell maturation, and
production of pro-inflammatory cytokines IL-6, TNF-α,
and IL-17 [14]. However, curcumin’s bioavailability is
limited after its ingestion. Piperine, a main component
present in pepper, has been reported not only to
increase absorption and bioavailability of curcumin by
more than 100% [15], but also to demonstrate in and of
itself anti-inflammatory [16], anti-tumor [17], and
immuno-modulatory [17-19] activities.
In rodents, high fat diet-induced obesity models are
the best parallels for human obesity [20]. Obese mice
infected with influenza virus have a higher mortality
associated with a significant reduction of NK cell cyto-
toxicity accompanied by a diminished release of IFN-α
and IFN-β, suggesting impaired immune function during
obesity [3]. Recent studies reported that obesity could also
result in a change in CD4+ T cell subsets, including pro-inflammatory Th1 and Th17 cells and anti-inflammatory
regulatory T cells (Treg) in adipose or immune-associated
tissues [21-23]. However, little is known about the impact
of CR on CD4+ T cell subpopulations, particularly in the
obese host. Further, it would be interesting to determine
whether the beneficial effect of CR on HFD-induced obes-
ity might be further potentiated by concurrent supple-
mentation with dietary spice curcumin, with or without
addition of piperine, to enhance bioavailability and/or
efficacy of curcumin. Therefore, we conducted the current
study to address these gaps in knowledge.
Materials and methods
Animals and diets
Eight-wk old male C57BL/6 mice (Jackson Laboratory)
were fed a Western style high fat diet (Harlan Teklad, for-
mulation #TD 06433, 44% calorie from fat) for 22 wk.
Mice were then divided into 5 groups (9–10 mice/group):
1) control (mice continuing on HFD ad libitum), 2) CR
(HFD intake reduced by 10% for 5 wk and then by 20%
for another 33 weeks), 3) CR + curcumin (1 g/kg diet),
4) CR + curcumin (1 g/kg) + piperine (50 mg/kg), and 5)
CR + piperine (50 mg/kg). CR diets were adjusted to
provide the same intake levels for total protein, minerals,
and vitamins as in the control HF diet. We intentionally
designed the study to mimic the situation in which obese
adults adopt a long term, healthy regimen from a given
point onward to see whether obesity-associated adverse
consequences can be prevented or diminished. The mice
were housed individually in shoebox polycarbonate cages
under 12 h light/dark cycles. Water was provided ad-
libitum, and mice were weighed weekly. At the end of the
study, mice were killed with CO2 asphyxiation followed by
exsanguination. Tissues were collected post-mortem. All
conditions and handling of the animals were approved by
the Animal Care and Use Committee of the Jean Mayer
USDA Human Nutrition Research Center on Aging at
Tufts University and conducted according to the NIH
Guidelines for the Care and Use of Laboratory Animals.
Total body fat
Total fat mass was measured using a magnetic reson-
ance imaging (MRI) machine, EchoMRI-100 (EchoMRI,
Houston, TX). Non-anesthetized mice were placed in a
restraining tube, which is inserted into the chamber unit
of the MRI machine, and then their body composition
(fat mass, lean mass, free water, and total body water)
was determined.
Plasma glucose and insulin
After mice were euthanized, plasma was collected and
stored at −80°C. Glucose and insulin concentrations in
the plasma were measured using Glucose Colorimetric
Assay Kit (Cayman Chemical Company, Ann Arbor, MI)
Figure 1 Effect of CR and spice compounds on body weight
and fat mass. Mice were fed experimental diets for 60 wk as
described in the “Materials and methods” section. Body weight and
fat mass were recorded at the time points as indicated. Values are
means ± SEM, n = 9-10 mice/group. HFD: high fat diet, CR: caloric
restriction, C: curcumin, P: piperine.
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Chem Inc., Downers Grove, IL), respectively, following
the kit instructions.
Splenocyte proliferation
After mice were euthanized, the spleens were aseptically
removed, and single-cell suspensions were prepared. Cells
were seeded into 96-well round-bottom cell culture plates
(2 × 105/well) and incubated in the presence of Con A
(Sigma-Aldrich, St. Louis, MO) at 0.5, 1.5, or 3 μg/ml,
PHA (Difco Laboratories, Detroit, MI) at 2.5, 5, or
20 μg/ml, or plate-coated anti-CD3 (5 μg/ml) plus soluble
anti-CD28 (1 μg/ml) (anti-CD3/CD28, BD Pharmingen,
San Diego, CA) for 72 h. Cultures were pulsed with [3H]-
thymidine (1 μCi/well, PerkinElmer Life Sciences, Boston,
MA) during the last 4 h. Cells were harvested by a
MicroBeta FilterMate Universal Harvester (PerkinElmer),
and cell proliferation was quantified as the amount of
[3H]-thymidine incorporated into DNA as determined by
liquid-scintillation counting in a MicroBeta2 Plate
Counter (PerkinElmer). Data are expressed as counts
per minute (cpm).
Cytokine production
Splenocytes in 24-well culture plates (3 × 106/well) were
cultured in the presence of lipopolysaccharide (LPS)
(1 μg/ml) for 24 h for production of inflammatory cyto-
kines IL-1β, IL-6, and TNF-α, and lipid inflammatory
mediator prostaglandin E2 (PGE2), or in the presence of
Con A (1.5 μg/ml) or plate-coated anti-CD3 (5 μg/ml)
plus soluble anti-CD28 (1 μg/ml) for 48 h for production
of T cell cytokines IFN-γ, IL-2, IL-4, and IL-10. The
supernatants were collected and measured using ELISA
for IL-1β (kit from R&D system, Minneapolis, MN),
IL-6, TNFα, IFN-γ, IL-2, IL-4, and IL-10 (all from BD
Pharmingen). PGE2 was measured using PGE2 kit from
Meso Scale Discovery (MSD, Gaithersburg, MD) and
analyzed using MSD platform.
Flow cytometry
To determine the percentage of Treg cells, splenocytes
were blocked using anti-CD16/32 (Fc block, BD
Pharmingen) and then multi-stained with fluorescence-
conjugated anti-CD4, anti-CD25, and anti-Foxp3 using
the mouse Foxp3 Buffer Set (all from BD Pharmingen).
To determine cytokine production, after splenocytes
were stimulated with 50 ng/ml PMA and 500 ng/ml
ionomycin (both from Sigma-Aldrich) in the presence of
monensin (BD Pharmingen) for 4 h, the cells were
blocked, fixed and permeabilized with Cytofix/Cytoperm
kit (BD Pharmingen), and stained with fluorescence-
conjugated antibodies. The antibodies used for flow cytom-
etry were as follows: anti-CD4, anti-IL-2, anti-IFN-γ, and
anti-IL-10 from eBiosciences, and anti-IL-4 and anti-IL-17 from BD Pharmingen. Cytometric measurements
were conducted using an Accuri C6 flow cytometer, and
acquired data were analyzed with FlowJo7.6 software
(Treestar Inc., Ashland, OR).Statistical analysis
All results were expressed as means ± SEM. Statistical ana-
lysis was conducted using Systat 12 statistical software. Dif-
ferences were determined using 1-way ANOVA followed
by Tukey’s HSD post hoc procedure. Significance was set
at P < 0.05.Results
Effect of CR, curcumin, and piperine on body weight and
total body fat
During the 22-wk of HFD feeding and prior to starting
CR and spice compound supplementation, mice in all
groups gained weight steadily. After the switching point
at wk 22, the mice in HFD control group continued to
gain weight, plateauing at wk 57 (3 wk before the end of
study), while the mice in all CR groups, with or without
curcumin or piperine supplementation, showed a similar
weight loss pattern: their weights fluctuated early on,
then dropped and stabilized, and eventually ended with
a significantly lower average weight compared to HFD
control group (Figure 1) by 17-19% (P < 0.001). Similar
to the changes in body weight, although with some delay
in time, all of the mice in the CR groups had less fat
mass compared to the HFD control group, regardless of
the presence of curcumin/piperine (Figure 1).
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Compared to the HFD control group, the mice in all CR
groups had lower plasma levels of glucose (Figure 2A) and
insulin (Figure 2B). However, the addition of curcumin
and/or piperine did not affect these CR-induced changes
(Figure 2).
Total spleen cell number and percent CD4+ T cells
Spleens from CR treated mice had lower total cell
counts compared to the mice in HFD control group
(Figure 3A), which reflected an overall smaller size of
spleens (data not shown) as we reported before [24]. In
agreement with a previous study [10], we also found that
CR treated mice had a higher percentage of CD4+ T cells
in total spleen cells (Figure 3B). However, the addition of
curcumin and/or piperine did not affect these CR-
induced changes (Figure 3).
Production of pro-inflammatory cytokines by splenocytes
Splenocytes from CR treated mice produced less IL-1β
and TNF-α compared to those from HFD control mice,
and this anti-inflammatory effect of CR was not further
potentiated by the concurrent supplementation with
curcumin and/or piperine (Figure 4A and B). IL-6,
another pro-inflammatory cytokine, also tended to be
lower in all CR groups but in the curcumin + piperine
group only, this decrease reached significance while in all
the other CR groups, there was a strong trend toward
decreases with varied p values at 0.06 to 0.08 (Figure 4C).
Splenocyte proliferation
In the ex vivo cell proliferation experiments, we used
different concentrations of T cell mitogens Con A and
PHA, and anti-CD3/CD28. Since the effects of treatment
on splenocyte proliferation was similar across concentra-
tions used, we only showed the results generated with
the optimal concentration of each stimulant used to
induce T cell proliferation in splenocytes, i.e., Con A at
1.5 μg/ml, PHA at 5 μg/ml, and plate-coated anti-CD3Figure 2 Effect of CR and spice compounds on plasma glucose and in
insulin (B) levels were determined by using Glucose Colorimetric Assay Kit an
SEM, n = 8 mice/group. Means without a common letter differ at P < 0.05. HFDat 5 μg/ml plus soluble anti-CD28 at 1 μg/ml. We found
that mice in only the CR group had higher levels of T
cell proliferation in response to all the stimulation con-
ditions compared to HFD control mice; however, this
effect of CR was lessened to varied degrees by the con-
current curcumin and/or piperine supplementation so
that proliferation levels in all the CR + curcumin and/or
piperine groups did not differ from either HFD or CR
group (Figure 5).
Ex vivo production of T cell cytokines by splenocytes
Secretion of selected T cytokines was determined using
ELISA in the cultures stimulated by either Con A or
anti-CD3/CD28. Similar to the results of splenocyte pro-
liferation, both Con A- and anti-CD3/CD28-stimulated
splenocytes from mice in only the CR group produced
more IL-2 compared to HFD control mice, and this effect
was lessened by the concomitant curcumin and/or piper-
ine supplementation (Figure 6A). No significant difference
was found in splenocyte production of IFN-γ (Figure 6B),
IL-4 (Figure 6C), and IL-10 (Figure 6D) across all groups.
To determine if the observed change, or lack thereof, in
cytokine production with CR was due to alteration in
synthesis or post-secretion regulation of the cytokines, we
determined the intracellular levels of these cytokines spe-
cifically in splenocytes using flow cytometry. As seen in
Figures 7A and B, the results are generally in agreement
with the above-mentioned observations. Furthermore, we
determined intracellular levels of pro-inflammatory cyto-
kine IL-17, the hallmark cytokine for Th17, and found no
difference between different groups (Figure 7C).
PGE2 production by splenocytes
Consistent with our previous results generated in mice
[24] and human subjects [7], we found that LPS-stimulated
PGE2 production by splenocytes in CR mice was signifi-
cantly lower than in HFD control mice. No further reduc-
tion in PGE2 production was observed by addition of
curcumin and/or piperine (Figure 8).sulin concentrations. Plasma was collected and the glucose (A) and
d Ultra Sensitive Mouse Insulin ELISA Kit, respectively. Values are means ±
: high fat diet, CR: caloric restriction, C: curcumin, P: piperine.
Figure 3 Effect of CR and spice compounds on total number of spleen cells and proportion of CD4+ T cells. Isolated splenocytes were
counted under microscope for total spleen cells (A) and stained with fluorescence-conjugated anti-CD4 antibody, followed by flow cytometry to
determine the splenic CD4+ T cell levels (B). Values are means ± SEM, n = 9 mice/group. Means without a common letter differ at P < 0.05. HFD:
high fat diet, CR: caloric restriction, C: curcumin, P: piperine.
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Increasing evidence points to the distinct roles of different
CD4+ T cell subsets in anti-microbial immune response, al-
lergies, tolerance, autoimmunity, and inflammation [25,26].
However, it is not known whether a combined CR and
spice supplementation regimen would affect CD4+ T cell
profiles as assessed by the production of their respective
signature cytokines. We found that CR alone resulted
in a higher production of IL-2 in CD4+ T cells, as indi-
cated by the presence of more IL-2 producing CD4+ T
cells, which was diminished when combined with spice
supplementation (Figure 9A). CR and spice compounds,Figure 4 Effect of CR and spice compounds on inflammatory cytokine
for 24 h and supernatant was used to determine production of IL-1β (A), T
group). Means without a common letter differ at P < 0.05. HFD: high fat dieeither alone or combined, had no effect on the proportion
of CD4+ T cell subsets Th1 (IFN-γ), Th2 (IL-4, IL-10),
Th17 (IL-17), and Treg cells (CD4+CD25+Foxp3+)
(Figure 9).
Discussion
It has been well-accepted that the high fat/high caloric
content present in the typical Western diet adversely
impacts health and is a common cause of obesity. In
turn, studies have provided evidence linking obesity to
the high risk of developing type 2 diabetes, cardiovascu-
lar disease, and metabolic syndrome. It is believed that aproduction by splenocytes. Spleen cells were stimulated with LPS
NF-α (B), and IL-6 (C) using ELISA. Values are means ± SEM (n = 9 mice/
t, CR: caloric restriction, C: curcumin, P: piperine.
Figure 5 Effect of CR and spice compounds on splenocyte
proliferation. Splenocytes were stimulated with T cell mitogen Con
A or PHA, or anti-CD3/CD28 at their optimal concentrations (1.5, 5,
5/1 μg/ml, respectively) for 72 h, and proliferation were determined
by [3H]-thymidine incorporation. Values are means ± SEM (n = 9
mice/group). Means without a common letter differ at P < 0.05. HFD:
high fat diet, CR: caloric restriction, C: curcumin, P: piperine.
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low-grade inflammatory state developed as a conse-
quence of increased adiposity, which has been supported
by numerous studies in the past decade. While the
obesity-associated inflammation has been extensivelyFigure 6 Effect of CR and spice compounds on T cell cytokine produc
coated anti-CD3 (5 μg/ml)/anti-CD28 (1 μg/ml) for 48 h and supernatant w
(B), IL-4 (C), IL-10 (D) using ELISA. Values are means ± SEM (n = 9 mice/grou
diet, CR: caloric restriction, C: curcumin, P: piperine.studied, the impact of obesity on the innate and adaptive
immune response, in particular that of T cell-mediated
function, has not been well-clarified thus far, though
available evidence suggests that obesity may compromise
the immune-surveillance pathways leading to impaired
immune response against pathogens [27]. Further, the
effect of weight reduction by CR and its combination
with spice components on immune and inflammatory
responses of obese mice has not been well-defined. Here
we report that CR results in a reduction in body weight,
fat mass, and inflammatory response, as well as an
enhancement in T cell-mediated function compared to
the mice fed the same high fat diet ad libitum. We also
report that the addition of spice components curcumin
and piperine does not further enhance CR’s benefit, but
rather it blunts the effect of CR on T cell-mediated
function.
In this study, we found that CR applied to the obese
mice provided metabolic benefits as indicated by the
reduced weight gain and fat mass and by lowered levels
of fast blood glucose and insulin. These results agree
with previous reports on CR in both humans [28,29] and
animals [30,31]. Contrary to what we anticipated, con-
current consumption of curcumin and/or piperine had
no further effect on these CR-induced changes. However,
this is consistent with the similar lack of additional
effects of these spice compounds on inflammationtion. Splenocytes were stimulated with Con A (1.5 μg/ml) and plate-
as collected to determine production of T cell cytokines IL-2 (A), IFN-γ
p). Means without a common letter differ at P < 0.05. HFD: high fat
Figure 7 Effect of CR and spice compounds on intracellular levels of T cell cytokines. Splenocytes were stimulated with 50 ng/ml PMA and
500 ng/ml ionomycin in the presence of Golgi Stop for 4 h and intracellular IL-2 and IFN-γ (A), IL-4 and IL-10 (B), and IL-17 (C) were determined
using flow cytometry. Values are means ± SEM (n = 9 mice/group). Means without a common letter differ at P < 0.05. HFD: high fat diet, CR: caloric
restriction, C: curcumin, P: piperine.
Figure 8 Effect of CR and spice compounds on LPS-stimulated
PGE2 production. Spleen cells were stimulated with LPS for 24 h
and supernatant was used to determine PGE2 production using a
MSD kit and platform. Values are means ± SEM (n = 6 mice/group).
Means without a common letter differ at P < 0.05. HFD: high fat diet,
CR: caloric restriction, C: curcumin, P: piperine.
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adiposity, inflammatory state, and glucose metabolism.
Previous studies have reported that CR administered
to lean or obese rodents increases total T cell population
and both CD4+ and CD8+ subpopulations [10,32,33].
Consistent with these previous results, in the current
study, which focused on CD4+ T cells and their subpop-
ulations, we found that spleens from CR mice had
higher percentages of CD4+ T cells. This increase in the
proportion of CD4+ T cells may partly explain the higher
levels of splenocyte proliferation in CR mice because
only T cells in the spleen cell mixture should proliferate
after being stimulated by T cell mitogens or TCR anti-
bodies, and a larger number of T cells to begin with
would be expected to result in a larger number of prolif-
erating cells in the end. However, we cannot rule out
that CR might have enhanced the T cell division and
thus the proliferation rate.
Also consistent with the previous studies showing
enhanced T cell proliferation and IL-2 production in CR
mice and humans [7,33-35], we found that obese mice
subjected to CR had higher levels of splenocyte prolifer-
ation and IL-2 production in response to both T cell
mitogen and anti-CD3/CD28 stimulation. Of note, CR
mice also had lower PGE2 production compared to the
control mice, which confirmed our previous findings in
Figure 9 Effect of CR and spice compounds on CD4+ T cell subpopulations. Splenocytes were stimulated with 50 ng/ml PMA and 500 ng/ml
ionomycin in the presence of Golgi Stop for 4 h. After that, appropriate surface and intracellular stainings were performed to identify CD4+ T
cell subpopulations as defined by their cytokine production pattern: Th1 (IL-2 and IFN-γ) (A), Th2 (IL-4 and IL-10) (B), Th17 (IL-17) (C), and Treg
(CD4+CD25+Foxp3+) (D) using flow cytometry. All analyses were performed within the gated CD4+ T cells. Values are means ± SEM (n = 9 mice/group).
Means without a common letter differ at P < 0.05. HFD: high fat diet, CR: caloric restriction, C: curcumin, P: piperine.
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for 13 mo in Emory mice reduced PGE2 production in
spleen [24]; in a recent human study, we found that 30%
CR for 6 mo decreased PGE2 production in LPS-
stimulated whole blood culture [7]. Given that PGE2 is a
suppressive factor for T cell proliferation and IL-2 pro-
duction [36-38], a reduction in PGE2 production by CR
represents another mechanism through which CR might
have improved T cell proliferation and IL-2 production
in obese mice. We did not evaluate the mechanism of
CR-induced decrease in PGE2 production in the current
study. However, a study by Kim et al. provided insight
into the underlying mechanism [39]. They reported that
in kidneys from CR rats, the activity of cyclooxygenase
(COX), a rate-limiting enzyme for eicosanoid synthesis,
was lower compared to the control rats, and this change
was accompanied by a lower expression of COX-2 at both
protein and mRNA levels [39]. Although their findings for
CR-induced changes were from different tissues (kidney
vs. spleen in the current study), we speculate that the
down-regulated COX-2 abundance/activity may represent
a common mechanism shared across different tissues for
the observed effect of CR on PGE2 production. CR’s
inhibitory effect on PGE2 production also provided
another piece of evidence to support the suggested anti-
inflammatory property of CR given the fact that PGE2 is avery potent lipid inflammatory mediator and it is involved
in the pathogenesis of many inflammatory diseases.
In this study, we found that CR’s enhancing effect on
T cell proliferation and IL-2 production was lessened by
supplementation of CR diets with spice compounds to
such a level that CR’s effect was no longer significant in
any of the CR groups that were supplemented with
curcumin and/or piperine. This may reflect a suppres-
sive effect of curcumin and piperine on T cell-mediated
functions as reported in several previous studies [40-44].
For example, it has been shown that dietary curcumin in
mice suppresses CD4+ T cell proliferation and IL-2 pro-
duction [43] while in vitro curcumin supplementation
inhibits T cell activation [44], human peripheral blood
mononuclear cell proliferation and IL-2 production
[40,42], and IL-2 synthesis as well as IL-2 signaling in
mouse CD4+ T cells [41]. Although little information is
available for piperine in this regard, some studies have
indeed suggested that piperine may inhibit T cell-related
functions [19,45].
Both CR and curcumin have been shown to have an
anti-inflammatory effect, respectively. Therefore, in this
study, we investigated whether inclusion of curcumin in a
CR diet would further potentiate CR’s beneficial effects.
While our results clearly showed an anti-inflammatory
effect of CR, which was indicated by a significant
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ward some reduction of IL-6, curcumin and piperine dem-
onstrated no additional benefits. These results lend
further support to the suggested beneficial effects of CR
toward mitigating inflammation caused by an HFD/obes-
ity condition. Of note, it was a study limitation that all
spice compound-supplemented mice were on CR treat-
ment; therefore, it is presently unknown whether these
bioactive compounds would have produced an anti-
inflammatory effect if administered to HFD control mice
without CR regimen.
An increased presence of immune cells in adipose tissue
is the hallmark of obesity-induced inflammation. Macro-
phages were first found in the adipose tissue of obese
animals and humans nearly a decade ago [46,47]. Emer-
ging evidence now suggests that during obesity, T cells
precede macrophages in entering adipose tissue and pro-
duce pro-inflammatory cytokines to activate macrophages.
It is still unresolved as to which of the CD4+ and CD8+ T
cells are the predominant T cells present in the adipose
tissue of obese humans and animals and how obesity
affects the balance within CD4+ T cells and among their
different subpopulations, i.e., Th1, Th2, Th17, Treg, etc.
The qualitative and quantitative changes in the immune
cells present in adipose tissue are proposed to be key
factors in the obesity-inflammation-metabolic disorder
pathway. In particular, different CD4+ T cell subsets have
recently attracted increasing attention due to the fact that
specific types of CD4+ T cells are known to play different
roles in maintaining homeostasis as well as regulating
immune and inflammatory responses [25,26]. In contrast
to our study’s hypothesis, we determined that CR and
spice compounds, alone or in combination, have no effect
on CD4+ subpopulations in peripheral lymphoid tissue
(spleen). This indicates that neither CR nor the spice com-
pounds affect CD4+ T cell differentiation under HFD/
obesity. However, it remains possible that CR may favor-
ably affect CD4+ T cell differentiation under certain other
conditions. In a recent study [48], CR in fact attenuated
experimental autoimmune encephalomyelitis (EAE, a ro-
dent model for multiple sclerosis) in mice, an autoimmune
disease driven by antigen-specific Th1 and Th17 response
and mitigated by Treg cells; however, CD4+ T cell subsets
were not examined in that study. Information regarding the
impact of spices on CD4 subpopulation is limited. Dietary
curcumin was shown to ameliorate EAE in rats through in-
hibition of Th17 response [49] and in mice through inhib-
ition of Th1/Th17 responses and enhancement of Th2/
Treg responses [50]. Taken together, these results indicate a
potential area for future studies to explore: whether the
beneficial effect of CR on autoimmune diseases is mediated
through its effect on CD4+ T cell differentiation and further,
whether CR interacts with spice compound supplementa-
tion to mutually potentiate their respective effectiveness.Conclusions
We have demonstrated that CR has a beneficial effect in
diet-induced obesity by suppressing the inflammatory re-
sponse and improving T cell-mediated function in obese
mice. This effect of CR on T cell mediated function
might be due in part to an increase in CD4+ cells and a
reduction in PGE2 production. Contrary to our hypoth-
esis, however, supplementation of CR diet with bioactive
spice compounds curcumin and/or piperine provides no
additional benefit; instead, they diminished CR’s effect
on T cell-mediated function. Future studies are needed
to further determine the mechanisms underlying these
observations as well as the applicability of these findings
to humans.
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